Bryce Vissel: Difference between revisions

Add links
From Wikipedia, the free encyclopedia
Browse history interactively
← Previous editNext edit →
Content deleted Content added
VisualWikitext
revert, multiple issues, links on body, primary sources, promo tone, copyrighted image (see https://www.giving.uts.edu.au/projects-and-causes/centre-for-neuroscience-and-regenerative-medicine) violates many policies
This page was incomplete. I have added details and information about his research, publications and career.
Line 1: Line 1:
{{Orphan|date=September 2018}}
{{Orphan|date=September 2018}}


'''Bryce Vissel''' is professor of [[neuroscience]] at the [[University of Technology Sydney]] and director of neuroscience and regenerative medicine in the Faculty of Science there. He is a specialist in [[neurodegenerative diseases]] such as [[Alzheimer's disease|Alzheimer's]], [[Parkinson's disease|Parkinson's]] and spinal disorders as well as studying the neural basis of learning and memory and movement.<ref>{{Cite web |url=https://www.uts.edu.au/staff/bryce.vissel# |title=Archived copy |access-date=2018-01-15 |archive-url=https://web.archive.org/web/20180115190331/https://www.uts.edu.au/staff/bryce.vissel# |archive-date=2018-01-15 |dead-url=yes |df= }}</ref><ref>{{cite web|url=https://www.spinalcure.org.au/dr-bryce-vissel/|title=Dr Bryce Vissel - Garvan Institute - SpinalCure Australia|website=Spinalcure.org.au|accessdate=15 January 2018}}</ref><ref>{{cite web|url=http://www.smh.com.au/technology/sci-tech/hope-for-the-paralysed-uts-to-establish-centre-for-neuroscience-and-regenerative-medicine-20160915-grgudc.html|title=Hope for the paralysed: UTS to establish Centre for Neuroscience and Regenerative Medicine|first=Marcus|last=Strom|date=16 September 2016|accessdate=15 January 2018|newspaper=[[The Sydney Morning Herald]]}}</ref>
'''Bryce Vissel''' is professor of [[neuroscience]] at the [[University of Technology Sydney]]. He is also the Director of the Centre for Neuroscience and Regenerative Medicine (CNRM)<ref>{{Cite web|url=https://www.sbs.com.au/news/new-technology-enables-paraplegic-patients-to-walk-again|title=New technology enables paraplegic patients to walk again|website=SBS News|language=en|access-date=2019-02-15}}</ref>. He is a specialist in [[neurodegenerative diseases]] such as [[Alzheimer's disease|Alzheimer's]], [[Parkinson's disease|Parkinson's]] and spinal disorders as well as studying the neural basis of learning and memory and movement.<ref>{{Cite web |url=https://www.uts.edu.au/staff/bryce.vissel# |title=Archived copy |access-date=2018-01-15 |archive-url=https://web.archive.org/web/20180115190331/https://www.uts.edu.au/staff/bryce.vissel# |archive-date=2018-01-15 |dead-url=yes |df= }}</ref><ref>{{cite web|url=https://www.spinalcure.org.au/dr-bryce-vissel/|title=Dr Bryce Vissel - Garvan Institute - SpinalCure Australia|website=Spinalcure.org.au|accessdate=15 January 2018}}</ref><ref>{{cite web|url=http://www.smh.com.au/technology/sci-tech/hope-for-the-paralysed-uts-to-establish-centre-for-neuroscience-and-regenerative-medicine-20160915-grgudc.html|title=Hope for the paralysed: UTS to establish Centre for Neuroscience and Regenerative Medicine|first=Marcus|last=Strom|date=16 September 2016|accessdate=15 January 2018|newspaper=[[The Sydney Morning Herald]]}}</ref>

=== Career ===
After achieving his PhD in medical genetics at the '''[[University of Melbourne]]''', Professor Vissel joined the '''[[Garvan Institute of Medical Research|Garvan Institute]]'''’s Neuroscience Division. He was subsequently awarded a '''[[National Health and Medical Research Council|NHMRC]] CJ Martin Fellowship'''<ref>{{Cite web|url=http://purl.org/au-research/grants/nhmrc/188819|title=The role of glutamate receptor mediated excititoxicity in neurodegeneration and Huntington's disease|website=Research Data Australia|language=en|access-date=2019-02-15}}</ref> to pursue neuroscience research with Professor Stephen Heinemann at the '''[[Salk Institute for Biological Studies|Salk Institute]]'''<ref>{{Cite web|url=https://www.scimex.org/experts?a=41380|title=Bryce Vissel - Scimex|website=www.scimex.org|access-date=2019-02-15}}</ref>.

During his decade at Salk, Professor Vissel authored seminal studies describing molecular mechanisms that regulate synaptic function, and the role of these mechanisms in behaviour, learning and memory, and neurological diseases. He also received a '''Human Frontiers Program Award'''<ref>{{Cite journal|last=Götz|first=Jürgen|last2=Schonrock|first2=Nicole|last3=Vissel|first3=Bryce|last4=Ittner|first4=Lars M.|date=2009-08-26|title=Alzheimer's Disease Selective Vulnerability and Modeling in Transgenic Mice|url=http://dx.doi.org/10.3233/jad-2009-1143|journal=Journal of Alzheimer's Disease|volume=18|issue=2|pages=243–251|doi=10.3233/jad-2009-1143|issn=1875-8908}}</ref> and a '''Fulbright Award'''<ref>{{Cite web|url=https://www.michaeljfox.org/foundation/researchers.php?id=1651|title=Bryce Vissel PhD|website=The Michael J. Fox Foundation for Parkinson's Research {{!}} Parkinson's Disease|access-date=2019-02-15}}</ref>.

In 2002, Professor Vissel returned to Garvan, taking up a position as Head of the Neurodegenerative Diseases Group before being recruited by UTS.

Professor Vissel and UTS established the CNRM in 2017<ref>{{Cite web|url=https://www.smh.com.au/healthcare/new-trial-aiming-to-repair-injured-spinal-cords-gives-new-hope-to-paralysed-australians-20171130-gzvzwe.html|title=New trial aiming to repair injured spinal cords gives new hope to paralysed Australians|last=Han|first=Esther|date=2017-12-03|website=The Sydney Morning Herald|language=en|access-date=2019-02-15}}</ref>. Incorporating facilities in Botany and '''[[St Vincent's Hospital, Sydney|St Vincent’s Hospital]]''', the Centre focuses on research of the brain and spinal cord.

Under Professor Vissel’s leadership, the CNRM’s Brain Regeneration Program has shown that repair appears possible in the Ca1 and CA3 regions of the hippocampus, the brain’s memory centre<ref>{{Cite web|url=https://www.ncbi.nlm.nih.gov/pubmed/19489097|title=Abdipranoto‐Cowley, A. , Park, J. S., Croucher, D. , Daniel, J. , Henshall, S. , Galbraith, S. , Mervin, K. and Vissel, B. (2009), Activin A Is Essential for Neurogenesis Following Neurodegeneration. STEM CELLS, 27: 1330-1346. doi:10.1002/stem.80|last=|first=|date=|website=|archive-url=|archive-date=|dead-url=|access-date=}}</ref>. These findings have potential to impact treatment of a range of diseases through stimulating the brain’s regenerative mechanisms, including Parkinson’s<ref>{{Cite journal|last=Stayte|first=Sandy|last2=Vissel|first2=Bryce|date=2014-08-19|title=Corrigendum: Advances in non-dopaminergic pharmacological treatments of Parkinson's disease|url=http://dx.doi.org/10.3389/fnins.2014.00254|journal=Frontiers in Neuroscience|volume=8|doi=10.3389/fnins.2014.00254|issn=1662-453X}}</ref>, Alzheimer’s, and other devastating conditions.

Professor Vissel was also instrumental in bringing [[University of California, Los Angeles|UCLA]]-based scientist '''Professor Reggie Edgerton'''’s<ref>{{Cite web|url=https://www.scimex.org/newsfeed/patients-with-severe-paralysis-regain-use-of-hands-and-fingers-through-work-of-ulcauts-scientists|title=Patients with severe paralysis regain use of hands and fingers for improved quality of life|last=SCIMEX|date=1524711600|website=Scimex|language=en|access-date=2019-02-15}}</ref> pioneering work on spinal cord injuries to the Australia<ref>{{Cite web|url=https://www.smh.com.au/healthcare/new-trial-aiming-to-repair-injured-spinal-cords-gives-new-hope-to-paralysed-australians-20171130-gzvzwe.html|title=New trial aiming to repair injured spinal cords gives new hope to paralysed Australians|last=|first=|date=|website=|archive-url=|archive-date=|dead-url=|access-date=}}</ref><ref>{{Cite web|url=https://www.abc.net.au/news/health/2018-11-01/neurotechnology-restores-walking-spinal-cord-injury/10446050|title=Swiss study gets three paraplegic patients on their feet again|last=Khan|first=Jo|date=2018-11-01|website=ABC News|language=en-AU|access-date=2019-02-15}}</ref><ref>{{Cite web|url=https://www.smh.com.au/technology/hope-for-the-paralysed-uts-to-establish-centre-for-neuroscience-and-regenerative-medicine-20160915-grgudc.html|title=Hope for the paralysed: UTS to establish Centre for Neuroscience and Regenerative Medicine|last=Strom|first=Marcus|date=2016-09-16|website=The Sydney Morning Herald|language=en|access-date=2019-02-15}}</ref>, where they plan to conduct the first neurostimulation trials in the Southern Hemisphere.

Professor Vissel is currently Chair of the '''Advisory Board of Cellmid Ltd'''<ref>{{Cite web|url=https://www.proactiveinvestors.com.au/companies/news/151825/cellmid-appoints-dr-bryce-vissel-as-chairman-of-scientific-advisory-board-63324.html|title=Cellmid appoints Dr Bryce Vissel as chairman of scientific advisory board|date=2015-07-08|website=Proactiveinvestors UK|language=en|access-date=2019-02-15}}</ref>.


==References==
==References==

Revision as of 09:59, 15 February 2019

Bryce Vissel is professor of neuroscience at the University of Technology Sydney. He is also the Director of the Centre for Neuroscience and Regenerative Medicine (CNRM)[1]. He is a specialist in neurodegenerative diseases such as Alzheimer's, Parkinson's and spinal disorders as well as studying the neural basis of learning and memory and movement.[2][3][4]

Career

After achieving his PhD in medical genetics at the University of Melbourne, Professor Vissel joined the Garvan Institute’s Neuroscience Division. He was subsequently awarded a NHMRC CJ Martin Fellowship[5] to pursue neuroscience research with Professor Stephen Heinemann at the Salk Institute[6].

During his decade at Salk, Professor Vissel authored seminal studies describing molecular mechanisms that regulate synaptic function, and the role of these mechanisms in behaviour, learning and memory, and neurological diseases. He also received a Human Frontiers Program Award[7] and a Fulbright Award[8].

In 2002, Professor Vissel returned to Garvan, taking up a position as Head of the Neurodegenerative Diseases Group before being recruited by UTS.

Professor Vissel and UTS established the CNRM in 2017[9]. Incorporating facilities in Botany and St Vincent’s Hospital, the Centre focuses on research of the brain and spinal cord.

Under Professor Vissel’s leadership, the CNRM’s Brain Regeneration Program has shown that repair appears possible in the Ca1 and CA3 regions of the hippocampus, the brain’s memory centre[10]. These findings have potential to impact treatment of a range of diseases through stimulating the brain’s regenerative mechanisms, including Parkinson’s[11], Alzheimer’s, and other devastating conditions.

Professor Vissel was also instrumental in bringing UCLA-based scientist Professor Reggie Edgerton’s[12] pioneering work on spinal cord injuries to the Australia[13][14][15], where they plan to conduct the first neurostimulation trials in the Southern Hemisphere.

Professor Vissel is currently Chair of the Advisory Board of Cellmid Ltd[16].

References

  1. ^ "New technology enables paraplegic patients to walk again". SBS News. Retrieved 2019-02-15.
  2. ^ "Archived copy". Archived from the original on 2018-01-15. Retrieved 2018-01-15. {{cite web}}: Unknown parameter |dead-url= ignored (|url-status= suggested) (help)CS1 maint: archived copy as title (link)
  3. ^ "Dr Bryce Vissel - Garvan Institute - SpinalCure Australia". Spinalcure.org.au. Retrieved 15 January 2018.
  4. ^ Strom, Marcus (16 September 2016). "Hope for the paralysed: UTS to establish Centre for Neuroscience and Regenerative Medicine". The Sydney Morning Herald. Retrieved 15 January 2018.
  5. ^ "The role of glutamate receptor mediated excititoxicity in neurodegeneration and Huntington's disease". Research Data Australia. Retrieved 2019-02-15.
  6. ^ "Bryce Vissel - Scimex". www.scimex.org. Retrieved 2019-02-15.
  7. ^ Götz, Jürgen; Schonrock, Nicole; Vissel, Bryce; Ittner, Lars M. (2009-08-26). "Alzheimer's Disease Selective Vulnerability and Modeling in Transgenic Mice". Journal of Alzheimer's Disease. 18 (2): 243–251. doi:10.3233/jad-2009-1143. ISSN 1875-8908.
  8. ^ "Bryce Vissel PhD". The Michael J. Fox Foundation for Parkinson's Research | Parkinson's Disease. Retrieved 2019-02-15.
  9. ^ Han, Esther (2017-12-03). "New trial aiming to repair injured spinal cords gives new hope to paralysed Australians". The Sydney Morning Herald. Retrieved 2019-02-15.
  10. ^ "Abdipranoto‐Cowley, A. , Park, J. S., Croucher, D. , Daniel, J. , Henshall, S. , Galbraith, S. , Mervin, K. and Vissel, B. (2009), Activin A Is Essential for Neurogenesis Following Neurodegeneration. STEM CELLS, 27: 1330-1346. doi:10.1002/stem.80". {{cite web}}: Cite has empty unknown parameter: |dead-url= (help)
  11. ^ Stayte, Sandy; Vissel, Bryce (2014-08-19). "Corrigendum: Advances in non-dopaminergic pharmacological treatments of Parkinson's disease". Frontiers in Neuroscience. 8. doi:10.3389/fnins.2014.00254. ISSN 1662-453X.{{cite journal}}: CS1 maint: unflagged free DOI (link)
  12. ^ SCIMEX (1524711600). "Patients with severe paralysis regain use of hands and fingers for improved quality of life". Scimex. Retrieved 2019-02-15. {{cite web}}: Check date values in: |date= (help)
  13. ^ "New trial aiming to repair injured spinal cords gives new hope to paralysed Australians". {{cite web}}: Cite has empty unknown parameter: |dead-url= (help)
  14. ^ Khan, Jo (2018-11-01). "Swiss study gets three paraplegic patients on their feet again". ABC News. Retrieved 2019-02-15.
  15. ^ Strom, Marcus (2016-09-16). "Hope for the paralysed: UTS to establish Centre for Neuroscience and Regenerative Medicine". The Sydney Morning Herald. Retrieved 2019-02-15.
  16. ^ "Cellmid appoints Dr Bryce Vissel as chairman of scientific advisory board". Proactiveinvestors UK. 2015-07-08. Retrieved 2019-02-15.


Flag of AustraliaBiography icon

This biography of an Australian academic is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Bryce_Vissel&oldid=883427705"